Eye drops for treatment of eye infections
Pro Research Analysisby 
Searched over 200M research papers
Antibiotic Eye Drops for Bacterial Eye Infections
Antibiotic eye drops are a mainstay for treating bacterial eye infections, but traditional formulations often require frequent dosing due to poor drug retention and absorption. Recent advances have led to improved formulations that enhance drug delivery and effectiveness. For example, a nanosuspension eye drop containing an ion-paired moxifloxacin complex (MOX–PAM NS) demonstrated significantly better ocular drug absorption and infection prevention compared to standard moxifloxacin drops, with once-daily dosing proving as effective as three-times-daily regimens in animal models of Staphylococcus aureus infection . Similarly, deep eutectic solvent-based microemulsions have been developed to increase the solubility and sustained release of antibiotics like chloramphenicol, resulting in higher corneal permeation and faster action against resistant bacteria such as MRSA compared to commercial drops .
Innovative approaches also include the use of mucoadhesive nanoparticles, such as chitosan-based systems loaded with antibiotics like ceftazidime. These formulations increase drug residence time on the ocular surface and provide prolonged drug release, potentially improving treatment outcomes for bacterial infections . Additionally, eye drops containing synthetic antimicrobial peptides, such as LyeTxI-b derived from spider venom, have shown potent activity against resistant bacterial keratitis with no observed ocular toxicity . Monocaprin-based eye drops have also demonstrated rapid bactericidal effects against Neisseria gonorrhoeae, a cause of gonococcal blindness, and remain stable and non-irritating over long periods .
Silver nanoparticle-based eye drops represent another promising alternative, offering strong antibacterial activity and effective biofilm penetration, which is crucial for treating bacterial keratitis. These formulations have outperformed commercial antibiotic drops in animal models and show minimal toxicity due to their stable, zwitterionic coating .
Antiviral Eye Drops for Viral Eye Infections
For viral eye infections such as herpes zoster ophthalmicus, new famciclovir eye drop formulations have been developed to provide controlled drug release and targeted delivery to the cornea and sclera. These formulations show good stability, non-irritancy, and effective drug diffusion, suggesting they may be a viable alternative to oral antiviral therapy for ocular herpes zoster .
Antifungal Eye Drops for Fungal Eye Infections
Natamycin remains a key chemical eye drop for treating fungal eye infections, particularly in neonates. It is effective due to its polyene antifungal properties, which inhibit fungal growth .
Herbal and Combination Eye Drops
Herbal eye drops, such as those containing neem, tulsi, kapur, and honey, have demonstrated antibacterial activity and may be effective against bacterial eye infections. Combining herbal and chemical components could lead to more effective antimicrobial formulations, especially for neonatal infections .
Eye Drops for Ocular Inflammatory Diseases
For inflammatory eye diseases like uveitis, multifunctional hydrogel eye drops incorporating corticosteroids and reactive oxygen species scavengers have shown improved bioavailability and anti-inflammatory effects, offering a promising approach for managing ocular inflammation .
Supportive Eye Drops for Healing
Topical insulin eye drops have been explored for promoting corneal healing in cases of infective keratitis with persistent epithelial defects. While results are mixed, insulin drops may aid healing, particularly when not used alongside other potentially toxic topical treatments .
Conclusion
Recent research highlights significant advancements in eye drop formulations for treating eye infections. Innovations such as nanosuspensions, mucoadhesive nanoparticles, antimicrobial peptides, silver nanoparticles, and novel antiviral and antifungal drops are improving drug delivery, efficacy, and patient convenience. These developments offer promising alternatives for managing bacterial, viral, and fungal eye infections, as well as ocular inflammation, with the potential to address challenges like drug resistance and poor patient adherence Josyula2021Domenech-Monsell2025Pedro2023+7 MORE.
Sources and full results
Most relevant research papers on this topic